Skip to main content

Advertisement

ADVERTISEMENT

Department

Conference Insider
04/22/2021
A chronic disease’s estimated annual cost varies depending on the method used to arrive at the calculation, with inconsistent differences across diseases.
A chronic disease’s estimated annual cost varies depending on the method used to arrive at the calculation, with inconsistent differences across diseases.
A chronic disease’s estimated...
04/22/2021
First Report Managed Care
Conference Insider
04/22/2021
“Asthma continues to be a disease with significant burden in the United States, and economic impact is significantly associated with asthma severity,” researchers wrote.
“Asthma continues to be a disease with significant burden in the United States, and economic impact is significantly associated with asthma severity,” researchers wrote.
“Asthma continues to be a...
04/22/2021
First Report Managed Care

Advertisement

Conference Insider
04/21/2021
Researchers recently advised that a unique criterion and process must be used to evaluate drugs for placement in a value-based formulary.
Researchers recently advised that a unique criterion and process must be used to evaluate drugs for placement in a value-based formulary.
Researchers recently advised...
04/21/2021
First Report Managed Care
Conference Insider
04/21/2021
Researchers presented data at AMCP 2021 on the effectiveness of physician follow-up phone calls compared to letters in an effort to reduce drug-related problems and unnecessary pharmacy drug spend for health plans.
Researchers presented data at AMCP 2021 on the effectiveness of physician follow-up phone calls compared to letters in an effort to reduce drug-related problems and unnecessary pharmacy drug spend for health plans.
Researchers presented data at...
04/21/2021
First Report Managed Care
Conference Insider
04/19/2021
“Although increases in utilization and cost to the plan were observed for many policies deemed appropriately archived, it was determined that the clinical benefits and the reduction in provider, member, and administrative burden offset the...
“Although increases in utilization and cost to the plan were observed for many policies deemed appropriately archived, it was determined that the clinical benefits and the reduction in provider, member, and administrative burden offset the...
“Although increases in...
04/19/2021
First Report Managed Care

Advertisement

Conference Insider
04/19/2021
According to research presented at AMCP 2021, although there is interest in expanding support offerings in the future, current care management and disease state education remain the mainstays of support among health care stakeholders for...
According to research presented at AMCP 2021, although there is interest in expanding support offerings in the future, current care management and disease state education remain the mainstays of support among health care stakeholders for...
According to research presented...
04/19/2021
First Report Managed Care
Conference Insider
04/19/2021
“This trend implies a significant opportunity to adopt greater pharmacogenomics testing to improve the benefit of medications in patients and reduce potential risks,” said researchers.
“This trend implies a significant opportunity to adopt greater pharmacogenomics testing to improve the benefit of medications in patients and reduce potential risks,” said researchers.
“This trend implies a...
04/19/2021
First Report Managed Care
Conference Insider
04/19/2021
According to data presented at AMCP 2021, there is evident variability among commercial health plans and their applied prescriber requirements—which can create access barriers for patients, especially those in need of specialty drugs.
According to data presented at AMCP 2021, there is evident variability among commercial health plans and their applied prescriber requirements—which can create access barriers for patients, especially those in need of specialty drugs.
According to data presented at...
04/19/2021
First Report Managed Care

Advertisement

Formulary Frontlines®
04/07/2021
Edan Stanley
"Seeing first-hand the aggressive nature of SCLC and knowing that the large majority of those diagnosed will experience relapse, I am excited to see an effective new treatment demonstrating durable responses," said William Jeffrey Petty, MD,...
"Seeing first-hand the aggressive nature of SCLC and knowing that the large majority of those diagnosed will experience relapse, I am excited to see an effective new treatment demonstrating durable responses," said William Jeffrey Petty, MD,...
"Seeing first-hand the...
04/07/2021
First Report Managed Care
Conference Insider
03/19/2021
In a study presented at the NCCN annual congress, Gel-LA was more likely to suppress testosterone rates over an extended period of time than Msphere-LA.
In a study presented at the NCCN annual congress, Gel-LA was more likely to suppress testosterone rates over an extended period of time than Msphere-LA.
In a study presented at the NCCN...
03/19/2021
Oncology

Advertisement